Low Back Pain

Low back pain (LBP) is the leading global cause of years lived with disability and a quintessential midlife-to-older-age phenotype ¹. It encompasses pain, muscle tension, or stiffness localized below the costal margin and above the inferior gluteal folds, with or without leg pain. In clinical practice, approximately 85–90% of cases have no precisely identifiable structural cause on imaging and are classified as non-specific or mechanical LBP ². The remainder are specific — caused by radiculopathy, fracture, malignancy, or inflammatory spondyloarthropathy.

This page is the clinical-syndrome anchor for LBP. The tissue substrate — disc cell biology, nucleus pulposus degeneration, annulus fibrosus fissuring — is covered on intervertebral-disc-degeneration (see that page for mechanistic depth). This page focuses on the clinical classification, the aging landscape, the radiographic-pain disconnect, the paraspinal muscle dimension, and the intervention evidence relevant to maintaining spinal health across the lifespan.

Classification

Mechanical / non-specific LBP (~85–90% of cases)

Pain presumed to originate from spinal structures (disc, facet joint, ligament, muscle) without a specific identifiable pathological diagnosis. This is the dominant clinical category. Subclassification by probable dominant driver:

Subtype	Clinical features	Age trend
Discogenic	Flexion-worsened; central/bilateral; radiates anteriorly or to buttocks; relieved by extension	Peak 30–50; declines as disc desiccates
Facet-mediated (zygapophyseal)	Extension/rotation-worsened; unilateral or bilateral; referred to buttock/posterior thigh; morning stiffness; relieved by flexion and sitting	Rises with age; dominant mechanism in 40–60+
Myofascial / paraspinal	Diffuse, poorly localized; spasm; aggravated by prolonged postures; often post-exertion or post-awkward-load	All ages; acute component often myofascial
Sacroiliac joint	Low/buttock pain; positive provocation tests (FABER, compression); young women > older adults	More common in younger adults; overlaps with facet-mediated in older cohorts

Note for the wiki user: The facet-mediated pattern (extension and rotation provoked, flexion-relieved, buttock referral) is qualitatively distinct from discogenic (flexion-provoked, extension-relieved). Acute “tweak” episodes — sudden onset on twisting or awkward load, protective paraspinal spasm, often unilateral — are common in both subtypes but especially typical of facet-mediated or myofascial insults, and are typically self-limited over days to weeks with continued activity. unsourced — clinical pattern description; cross-check against a clinical reference source.

Specific LBP (~10–15% of cases)

Requires targeted workup and management:

Radiculopathy / disc herniation — leg pain in a dermatomal distribution (below the knee), neurological signs; positive straight-leg raise
Spinal stenosis — neurogenic claudication (bilateral leg pain/weakness relieved by flexion); older adults predominate
Vertebral compression fracture — acute onset in osteoporotic spine (older women); point tenderness over spinous process
Inflammatory spondyloarthropathy — morning stiffness >45 min, young age (<45), improves with activity; elevated CRP/ESR
Serious pathology (“red flags”) — malignancy, infection, cauda equina syndrome — require urgent investigation

Why LBP rises with age: the aging substrate

LBP is not a single-tissue disease. The age-related increase in prevalence and disability reflects parallel aging changes across multiple spinal structures, each linked to hallmarks of aging.

1. Intervertebral disc degeneration — altered load transfer

The most extensively studied substrate. See intervertebral-disc-degeneration for molecular detail. Key points for clinical context:

Nucleus pulposus hydration and proteoglycan content decline progressively after the 3rd decade
Annulus fibrosus fissures accumulate; disc height is lost
Load shifts from the hydraulic disc to the facet joints and annular ring — this is the mechanical link to facet-mediated LBP
Hallmarks engaged: cellular-senescence in nucleus pulposus cells, stem-cell-exhaustion (nucleus pulposus progenitors), chronic-inflammation (SASP-driven catabolic milieu)

Facet (zygapophyseal) joints are synovial joints subject to the same osteoarthritic process as peripheral joints — see osteoarthritis for the canonical mechanism. Age-related features:

Cartilage thinning, osteophyte formation, synovial inflammation
Capsular laxity with micro-instability and entrapped synovial folds (potential source of acute pain episodes)
Prevalence increases markedly after 50; by 70+ it is nearly universal on imaging ²
Hallmarks engaged: chronic-inflammation, cellular-senescence in chondrocytes

3. Paraspinal muscle atrophy and fatty infiltration

A frequently underappreciated aging driver. The multifidus and erector spinae muscles provide dynamic stability to the lumbar spine; their atrophy with age directly increases facet and disc loading.

Quantitative aging trajectory: fatty infiltration of lumbar paravertebral muscles is age- and level-dependent, detectable in healthy volunteers and rising progressively across decades on MRI ³. A 15-year longitudinal cohort showed that paraspinal muscle cross-sectional area (CSA) and fat fraction both change unfavorably with age, independent of physical activity ⁴.

Bidirectionality: LBP and paraspinal atrophy are mutually reinforcing — pain reduces activity, which accelerates disuse atrophy, which further destabilizes the spine ⁵. Sarcopenia (systemic) and lumbar muscle degeneration co-occur at above-chance rates in older LBP cohorts ⁵.

Hallmarks engaged: stem-cell-exhaustion (satellite cell depletion impairs paraspinal muscle regeneration after micro-injury), chronic-inflammation (inflammatory cytokines drive muscle catabolism via UPS/autophagy imbalance — see sarcopenia for the canonical mechanism), mitochondrial-dysfunction.

Cross-links: sarcopenia, skeletal-muscle.

4. Vertebral changes and osteoporotic fracture

Cortical thinning and trabecular microarchitectural loss — see osteoporosis and bone
Vertebral compression fractures cause acute LBP and persistent deformity in osteoporotic older adults (predominantly women post-menopause; prevalence ~25% in women >80 per some estimates) unsourced
Sub-clinical microfractures may contribute to chronic pain without complete vertebral collapse
Hallmarks engaged: cellular-senescence in osteocytes, stem-cell-exhaustion in mesenchymal stem cells, deregulated-nutrient-sensing

Hallmark map summary

Hallmark	Spinal tissue affected	Mechanism
cellular-senescence	Nucleus pulposus cells, chondrocytes, osteocytes	SASP-driven catabolic cytokine milieu; reduced matrix synthesis
chronic-inflammation	All disc/facet/muscle compartments	Systemic inflammaging lowers pain threshold; local TNF-α/IL-6/IL-1β drive catabolism
stem-cell-exhaustion	Nucleus pulposus progenitors, satellite cells, mesenchymal stem cells	Impaired regenerative capacity after micro-injury
deregulated-nutrient-sensing	Disc (avascular) + bone	mTOR/AMPK imbalance impairs autophagy and matrix maintenance in disc cells
mitochondrial-dysfunction	Paraspinal muscle	Reduced oxidative capacity; fatigue susceptibility

The radiographic-pain disconnect

This is one of the most clinically important facts in spinal medicine: degenerative MRI findings are extremely common in asymptomatic individuals and increase monotonically with age.

The Brinjikji et al. 2015 systematic literature review of imaging in asymptomatic populations found ⁶:

Finding	Age 20	Age 40	Age 60	Age 80
Disc degeneration	37%	68%	88%	96%
Disc height loss	24%	45%	67%	84%
Disc bulge	30%	50%	69%	84%
Disc protrusion	29%	33%	38%	43%
Annular fissure	19%	22%	25%	29%

These findings were pooled from 33 studies (n = 3,110 asymptomatic subjects). The implication is stark: most degenerative MRI findings in a person presenting with LBP are likely incidental rather than causally responsible for the pain, and imaging-driven management (unnecessary surgery, fear-avoidance behaviors) can worsen outcomes.

The complementary question — what converts structural degeneration into symptomatic pain — remains incompletely understood. Candidate mechanisms include: inflammatory activation at a threshold lesion, nociceptor sensitization by inflammatory mediators (substance P, CGRP, prostaglandins), ingrowth of nociceptive nerve fibers into degenerate discs, and central sensitization. no-mechanism — the critical transition from asymptomatic degeneration to pain is not mechanistically resolved.

Practical implication: imaging findings should be interpreted in clinical context; “degenerative changes at L4–L5” or “disc bulge at L3–4” in a 50-year-old is a description of normal aging, not necessarily a diagnosis.

Epidemiology and global burden

LBP is the leading cause of YLD globally and has held this rank since at least GBD 2010 ⁷. Key figures from GBD 2021 ¹:

Estimated 619 million cases globally in 2020 (age-standardized prevalence ~7.5%)
Projected to exceed 843 million by 2050, driven largely by population aging and growth in low-/middle-income countries
Age-standardized incidence: highest in 35–65 age group; absolute burden peaks in 50–74
Attributable risk factors in older adults: occupational exposures, smoking (impairs disc nutrition via microvasculopathy), high BMI, low physical activity

The Lancet 2018 series on LBP placed it in the broader framing of a condition frequently medicalized inappropriately: most episodes are self-limiting, but a minority (~10%) transition to chronic disabling pain ².

Clinical pattern: acute episodes in midlife

The quintessential presentation in the 40–65 age group: sudden onset of LBP after a twist, awkward lift, or even trivial movement; protective paraspinal muscle spasm; pain that worsens with extension/rotation (facet-mediated pattern) or flexion (discogenic); often self-limited over days to 4 weeks with continued activity.

Prognosis: ~60–70% of acute episodes resolve within 6 weeks regardless of treatment; ~30–40% have recurrence within 1 year; ~10% develop chronic (>12 weeks) pain. The transition to chronicity involves psychological factors (fear-avoidance beliefs, catastrophizing), sleep disruption, and central sensitization — not purely structural progression.

Bed rest is contraindicated — staying active and maintaining movement shortens episodes and reduces recurrence risk ⁸.

Interventions: aging-context evidence

Exercise — the best-evidenced long-term strategy

Exercise is the only intervention with strong, consistent meta-analytic evidence for both acute episode recovery and long-term prevention of recurrence and disability in older adults ⁸.

The Cochrane review (Hayden et al. 2021) — 249 RCTs, 24,486 participants — found exercise therapy reduces pain and disability in chronic LBP vs no treatment/usual care/placebo (MD −15.2 points on a 0–100 pain scale, 95% CI −18.3 to −12.2, at earliest follow-up; MD −6.8 for functional limitations, 95% CI −8.3 to −5.3); moderate-certainty evidence; effect maintained at medium-term follow-up ⁸. Cross-link: exercise.

What type of exercise? A 2022 network meta-analysis (Fernández-Rodríguez et al.) comparing exercise modalities in chronic LBP found strength/resistance training, Pilates, and mind-body (yoga/tai chi) all superior to usual care, with strength and core-based exercise performing best for pain reduction in head-to-head comparisons ⁹. Resistance and core-stabilization training (paraspinal + glute strengthening) are particularly relevant in the aging context:

Maintains multifidus and erector spinae cross-sectional area, counteracting age-related atrophy and fatty infiltration
Reduces facet and disc loading by improving dynamic spinal stability
Frames mechanically with the anti-sarcopenia strategy — maintaining paraspinal and trunk muscle mass is geroprotective for spinal stability, with effects that compound over time

The recent RCT by Santos et al. (2025) in older women with chronic LBP found both resistance-based and functional training protocols significantly reduced pain intensity and disability vs baseline ¹⁰.

Anti-sarcopenia framing: the paraspinal muscle atrophy trajectory is the same biological process as sarcopenia of the limb muscles, driven by the same hallmarks (stem-cell-exhaustion, chronic-inflammation, disuse). Treating LBP purely as a structural (disc/facet) problem without addressing paraspinal muscle mass misses a major modifiable contributor in older adults.

Passive modalities — limited long-term evidence

Manual therapy (spinal manipulation / mobilization): short-term benefit for acute LBP; evidence for chronic LBP is moderate and effect size small; not recommended as sole long-term strategy
NSAIDs / analgesics: useful for acute pain management; long-term use in older adults carries cardiovascular, GI, and renal risk
Epidural steroid injections: evidence for short-term pain relief in radiculopathy; evidence for non-specific LBP is weaker; recent review in older adults shows modest short-term benefit but durability unclear ¹¹
Opioids: not recommended for chronic non-specific LBP (risk-benefit unfavorable, especially in older adults)

Senolytic thread — via disc degeneration

Senescent nucleus pulposus cell accumulation drives SASP-mediated disc degeneration. Preclinical evidence for senolytic approaches (dasatinib + quercetin, fisetin, navitoclax) in disc degeneration models exists but is not yet tested in humans in this context. See intervertebral-disc-degeneration for the senolytic evidence thread. needs-human-replication.

Limitations and gaps

Radiographic-pain mechanism — the transition from asymptomatic degeneration to symptomatic LBP is not mechanistically explained; candidate mechanisms (nociceptor ingrowth, inflammatory activation) lack definitive causal evidence in humans. no-mechanism
Paraspinal muscle—pain causality — paraspinal atrophy and LBP are correlated but the directionality is difficult to establish in cross-sectional studies; longitudinal intervention studies measuring both muscle mass and pain outcomes are sparse. needs-replication
Facet-mediated vs discogenic differentiation — no non-invasive gold standard distinguishes facet-mediated from discogenic pain; diagnostic blocks (with corticosteroid or anesthetic) have procedural risk and are used selectively. no-mechanism
ICD-11 code — ME84.2 assigned as provisional; verify against current WHO ICD-11 coding tool before clinical use. icd11-unverified
Senolytic interventions — preclinical disc data has not been translated to clinical LBP trials; the mechanistic link from senescent cell clearance to symptomatic pain reduction in humans is untested. needs-human-replication
Aging-specific RCT power — most exercise RCTs for LBP do not stratify by age or separately power analyses for older adults (>65); the Santos 2025 and Weiner 2026 RCTs are exceptions.

Footnotes

doi:10.1016/s2665-9913(23)00098-x · GBD 2021 Low Back Pain Collaborators · Lancet Rheumatology 2023;5(7):e316–e329 · systematic analysis of Global Burden of Disease Study 2021 · n=619 million prevalent cases globally in 2020 (95% UI 554–694 million); projected 843 million (95% UI 759–933 million) by 2050 · age-standardised prevalence rate 7460 per 100,000 (6690–8370) in 2020; YLD rate 832 per 100,000 (578–1070); 38.8% of YLDs attributed to occupational factors, smoking, and high BMI · design: systematic review + burden modeling · local PDF: ↩ ↩²
doi:10.1016/S0140-6736(18)30480-X · Hartvigsen J, Hancock MJ, Kongsted A, et al. · Lancet 2018;391(10137):2356–2367 · Series Paper 1: “What low back pain is and why we need to pay attention” · design: review / Lancet series overview · n=not applicable · cited_by: 4296 · covers classification, global burden, natural history, and medicalization ↩ ↩² ↩³
doi:10.3174/ajnr.A4596 · Crawford RJ, Filli L, Elliott JM, et al. · AJNR Am J Neuroradiol 2016;37(4):742–748 · “Age- and level-dependence of fatty infiltration in lumbar paravertebral muscles of healthy volunteers” · design: cross-sectional MRI · n=healthy volunteers (asymptomatic) · fat fraction rises progressively with age and is level-dependent in lumbar paraspinal muscles ↩
doi:10.1249/MSS.0000000000000179 · Fortin M, Videman T, Gibbons LE, Battié MC · Med Sci Sports Exerc 2014;46(5):893–901 · “Paraspinal muscle morphology and composition: a 15-yr longitudinal magnetic resonance imaging study” · design: longitudinal cohort · n=not extracted (closed-access PDF — no-fulltext-access) · both CSA and fat fraction changed unfavorably over 15 years independent of physical activity ↩
doi:10.1016/j.afos.2017.09.001 · Sakai Y, Matsui H, Ito S, et al. · Osteoporos Sarcopenia 2017;3(4):195–200 · “Sarcopenia in elderly patients with chronic low back pain” · design: observational cross-sectional · model: human · sarcopenia co-occurrence in older LBP cohort; bidirectional relationship between muscle degeneration and pain behavior described ↩ ↩²
doi:10.3174/ajnr.A4173 · Brinjikji W, Luetmer PH, Comstock B, et al. · AJNR Am J Neuroradiol 2015;36(4):811–816 · “Systematic literature review of imaging features of spinal degeneration in asymptomatic populations” · design: systematic literature review · n=3,110 asymptomatic subjects across 33 studies · disc degeneration prevalence by decade tabulated; see body for the age-stratified table · cited_by: 1103 · local PDF confirmed (downloaded 2026-05-31) ↩
doi:10.1136/annrheumdis-2013-204428 · Hoy D, March L, Brooks P, et al. · Ann Rheum Dis 2014;73(6):968–974 · “The global burden of low back pain: estimates from the Global Burden of Disease 2010 study” · design: systematic review + burden modeling · YLD rank: #1 globally · cited_by: 3105 ↩
doi:10.1002/14651858.CD009790.pub2 · Hayden JA, Ellis J, Ogilvie R, Malmivaara A, van Tulder MW · Cochrane Database Syst Rev 2021;9:CD009790 · “Exercise therapy for chronic low back pain” · design: systematic review + meta-analysis · n=24,486 across 249 RCTs · MD −15.2 (95% CI −18.3 to −12.2) for pain on 0–100 scale vs no treatment/usual care/placebo at earliest follow-up; MD −6.8 (95% CI −8.3 to −5.3) for functional limitations; moderate-certainty evidence; effects maintained at medium-term follow-up · local PDF: ↩ ↩² ↩³
doi:10.2519/jospt.2022.10671 · Fernández-Rodríguez R, Álvarez-Bueno C, Cavero-Redondo I, et al. · J Orthop Sports Phys Ther 2022;52(7):505–521 · “Best exercise options for reducing pain and disability in adults with chronic low back pain” · design: systematic review + network meta-analysis · strength/resistance and core-based exercise ranked highest for pain reduction; Pilates and mind-body also superior to usual care ↩
doi:10.1016/j.jmpt.2024.09.012 · Santos PJ, Aragão-Santos JC, Santos TS, et al. · J Manipulative Physiol Ther 2025 · “Effects of 2 training protocols on aspects of pain in older women with chronic low back pain” · design: randomized controlled trial · n=older women · both resistance-based and functional training protocols significantly reduced pain intensity and disability; recency-search sourced (2025 publication) ↩
doi:10.1007/s40520-026-03336-0 · Zhu AC, Mysior CR, LaRowe LR, et al. · Aging Clin Exp Res 2026 · “Effectiveness of epidural steroid injections for low back pain in older adults” · design: systematic review · modest short-term benefit in older adults; durability unclear; recency-search sourced (2026 publication) ↩

🧬 Aging Wiki

Explorer

low-back-pain